Melagatran, Ximelagatran OverviewXimelagatran (Exanta or Exarta, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy. In 2006, its manufacturer AstraZeneca announced that it would withdraw pending applications for marketing approval after reports of hepatotoxicity (liver damage) during trials, and discontinue its distribution in countries where...
Read more Melagatran, Ximelagatran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ximelagatran
Recent Melagatran, Ximelagatran Forums:Be the first to start a discussion about this drug.
Other drugs which contain Melagatran, Ximelagatran or a similar ingredient: (1 result)
- EXANTA Melagatran, Ximelagatran